PAR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Paradigm Biopharmaceuticals Ltd

Watchlist Manager

Watchlist

Price: 0.165 AUD -5.71% Market Closed

Market Cap: AU$74.5m

	Paradigm Biopharmaceuticals Ltd ASX:PAR	AU
	IAR Systems Group AB OTC:IARGF	SE
	Western Forest Products Inc TSX:WEF	CA
B	Boeing Co SGO:BA	US

Profitability Summary

Paradigm Biopharmaceuticals Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

100%

Gross Margin is Increasing

99% > 100%

Negative Operating Margin

-495%

Negative 3Y Average Operating Margin

-563%

Operating Margin is Increasing

-496% > -495%

Negative Net Margin

-519%

Negative 3Y Average Net Margin

-574%

Declining Net Margin

-495% > -519%

Negative Free Cash Flow Margin

-230%

Negative 3Y Average Free Cash Flow Margin

-672%

Free Cash Flow Margin is Increasing

-373% > -230%

Negative ROE

-180%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-2 081%

ROIC is Increasing

-953% > -492%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

100%

Strong 3Y Average Gross Margin

100%

Gross Margin is Increasing

99% > 100%

Negative Operating Margin

-495%

Negative 3Y Average Operating Margin

-563%

Operating Margin is Increasing

-496% > -495%